JMKX000623

DRUG2 trials

Sponsors

Jemincare

Conditions

Diabetic Peripheral Neuropathic PainDrug-Drug InteractionHealthy

Phase 1

A DDI Study of JMKX000623 and Metformin Hydrochloride

CompletedNCT06066060

JemincareDrug-Drug Interaction, Healthy

Start: 2023-09-17End: 2023-11-06Updated: 2024-04-25

Phase 2

Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain

RecruitingNCT06221241

JemincareDiabetic Peripheral Neuropathic Pain

Start: 2024-03-25End: 2025-04-30Target: 220Updated: 2024-04-16